Alsalloum, A.; Alrhmoun, S.; Shevchenko, J.; Fisher, M.; Philippova, J.; Perik-Zavodskii, R.; Perik-Zavodskaia, O.; Lopatnikova, J.; Kurilin, V.; Volynets, M.;
et al. TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. Biomedicines 2023, 11, 2805.
https://doi.org/10.3390/biomedicines11102805
AMA Style
Alsalloum A, Alrhmoun S, Shevchenko J, Fisher M, Philippova J, Perik-Zavodskii R, Perik-Zavodskaia O, Lopatnikova J, Kurilin V, Volynets M,
et al. TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. Biomedicines. 2023; 11(10):2805.
https://doi.org/10.3390/biomedicines11102805
Chicago/Turabian Style
Alsalloum, Alaa, Saleh Alrhmoun, Julia Shevchenko, Marina Fisher, Julia Philippova, Roman Perik-Zavodskii, Olga Perik-Zavodskaia, Julia Lopatnikova, Vasily Kurilin, Marina Volynets,
and et al. 2023. "TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors" Biomedicines 11, no. 10: 2805.
https://doi.org/10.3390/biomedicines11102805
APA Style
Alsalloum, A., Alrhmoun, S., Shevchenko, J., Fisher, M., Philippova, J., Perik-Zavodskii, R., Perik-Zavodskaia, O., Lopatnikova, J., Kurilin, V., Volynets, M., Akahori, Y., Shiku, H., Silkov, A., & Sennikov, S.
(2023). TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. Biomedicines, 11(10), 2805.
https://doi.org/10.3390/biomedicines11102805